EMA — authorised 8 July 2019
- Status: approved
🇪🇺 Talzenna in European Union
EMA authorised Talzenna on 8 July 2019
Marketing authorisation
Talzenna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Talzenna approved in European Union?
Yes. EMA authorised it on 8 July 2019.
Who is the marketing authorisation holder for Talzenna in European Union?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.